In postmenopausal women, high testosterone levels increase the risk for insulin resistance, metabolic syndrome, and coronary heart disease, a new study shows.
Read More »Sugar Substitutes Increase Release of GLP-1
Combining artificial sweeteners with the real thing boosts the stomach’s secretion of a hormone that makes people feel full and helps control blood sugar, new research shows.
Read More »FDA Confirms Benefits of Crestor in Patients without Elevated Cholesterol
Federal scientists say AstraZeneca’s cholesterol pill Crestor lowers the risk of heart attack, death and stroke in patients without a history of heart disease, though some safety concerns remain.
Read More »Diabetes Risk Depends on Which Parent a DNA Variant Is Inherited From
Icelandic biologists have discovered that the genetic risk of several common diseases, like Type 2 diabetes and cancer, can depend on which parent a DNA variant is inherited from….
Read More »Eating Out Too Often Can Increase Risk of Type 2 Diabetes
Those who ate two meals per week of fried chicken were at 68 percent increased risk of Type 2 diabetes, compared to those who ate none.
Read More »Glycemic Index Education Leads to Better Diabetes Control
Nine weeks of education about the glycemic index in foods is enough to encourage adults with Type 2 diabetes to adopt better dietary habits that result in improvements to their health, recent research suggests.
Read More »Discovery of New Gene Called Brd2 that Regulates Obesity and Diabetes
The chance discovery of a genetic mutation that makes mice enormously fat but protects them from diabetes has given researchers at Boston University School of Medicine, MA, new insights into the cellular mechanisms that link obesity to Type 2 diabetes.
Read More »Treating Depression in Low-Income Diabetes Patients Improves Glycemic Control
Treatment of depression in low-income minorities with poorly controlled diabetes improves HbA1c and systolic blood pressure, investigators report.
Read More »Saxagliptin Improves Glycemic Control in Type 2 Diabetes Patients
Saxagliptin added to a thiazolidinedione improved glycemic control in Type 2 diabetes patients, in a phase III trial.
Read More »Roche’s Weekly GLP-1 Candidate Taspoglutide Found Effective
According to a head-to-head Phase III trial with Lantus (insulin glargine), taspoglutide is found to be equally effective.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.